FDA Inspection
VitalantVitalant – FDA Inspection, Oct 22, 2014
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on October 22, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- October 22, 2014
- Product Type
- Biologics
View Company Profile
ID · 2359e8df-cbb3-4b30-bf2b-30d836abf3e3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 900974
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 12, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 30, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 20, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 23, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 20, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1261748 - 2025-02-12
- FDA Inspection 1095064 - 2019-05-30
- FDA Inspection 1019097 - 2017-07-20
- FDA Inspection 829293 - 2013-04-23
- FDA Inspection 726389 - 2011-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.